Investment portfolio (30/06/2024).
We provide smart capital for Belgian innovation and driving socio-economic growth.
Our role is to create
sustainable long-term value.
all our investments are driven by our values.
EXEVIR BIO
Détention du capital13.42 %
ExeVio Bio is a spin-off of the Flemish Institute for Biotechnology (known by the Dutch acronym VIB). It draws on its llama nanobody technology to focus on the design of a therapeutic treatment for COVID-19 and other potential beta coronavirus-related diseases.
EYED PHARMA
Détention du capital8.33 %
Pharmaceutical company dedicated to the development of pharmaceutical products in ophthalmology
FIDENTIA BELUX INVESTMENTS (Fidentia II)
Détention du capital14.50 %
Investment fund in office buildings with a green certificate. These buildings are located in the Benelux, France and Germany.
FIDENTIA GREEN BUILDINGS
Détention du capital21.33 %
Company operating as a fund in order to develop, construct and sell low energy buildings.
FLUXYS
Détention du capital3.44 %
The company is the network operator for transport and storage of gas in Belgium and abroad. Its business concerns transportation, storage and freight, including a LNG on-site facility shipping out of Zeebrugge.
Fluxys c grid
Détention du capital2.5 %
FOMCAP IV PRIVAK/ FORCE OVER MASS
Détention du capital4.89 %
FOMCAP IV is the fourth fund of the London-based venture capitalist Force Over Mass. The fund invests in very young European growth companies (seed and series A) in the following sectors: fintech, artificial intelligence, software as a service and industry 4.0.
FORTINO CAPITAL I ARKIV
Détention du capital10.82 %
Investment fund that invests in technology companies with strong growth potential and in companies undergoing digital transformation, especially in the Benelux.
FORTINO CAPITAL VENTURE II
Détention du capital9.52 %
Established in early 2020, Fortino Capital Ventures II is a follow-on investment fund to Fortino Capital Ventures I Arkif. Investing in technology companies with high growth potential and those undergoing digital transformation.
FUND +
Détention du capital20.18 %
Fund+ is a limited company whose social purpose is to act as company investment and financing of companies active in the sector of life sciences, especially in technology, development and applications in this field.
FUNDCO EP
Détention du capital25.02 %
Public limited company under Luxembourg law.
GINKGO FUND II
Détention du capital10.78 %
Fund active in the acquisition, rehabilitation and development of contaminated or demarcated areas in urban areas in France or Belgium with a view to their return to the real estate market.
GOOD HARVEST VENTURES
Détention du capital14.78 %
Astanor's Good Harvest Ventures I fund brings together capital, deep sector knowledge and disruptive technologies to create a food future that is nourishing, regenerative, scalable, reliable and that provides food for all, while contributing to the “net zero” objective. Good Harvest Ventures I was established to invest primarily in equities in early-stage and early-growth technology companies active in the food and agriculture sector.
HERAN HEALTH TECH FUND I COMMV
Détention du capital9.27 %
The Heran HealthTec Fund I is one of the most specialised funds in the Belgian venture capital sector. It invests exclusively in health tech, i.e. in companies at the crossroads between IT and healthcare. These are mainly software solutions that help to analyse and/or manage medical data in the different phases of healthcare. Artificial intelligence is frequently used.